Addition of SensoMotoric Instruments technology adds capabilities in ocular surgery guidance technology to Alcon's existing global cataract portfolio.
Welcome to ModernMedicine
Alcon's LensSx SoftFit Patient Interface provides the latest update to the LenSx laser system for refractive cataract surgery.
Presbia announces that the Presbia Flexivue Microlens implantable corneal inlay for presbyopia is now under active consideration for an IDE.
Focal lamina cribrosa defects were highly correlated with glaucomatous structural and functional damage in an evaluation performed with EDI-OCT.
Prevent Blindness America’s Most Beautiful Eyes Contest emphasizes that keeping children’s eyes and vision healthy should be a priority for everyone.
The LEITR 2012 Eye Ball Gala helps raise approximately $125,000 and showcases the need for ocular advancements and research for the blind and visually impaired.
KalVista Pharmaceuticals has received a £2.4 million grant to accelerate development of an oral plasma kallikrein inhibitor for the treatment of diabetic macular edema.
Randomized clinical trials provide insight on relative efficacy and safety of popular aqueous shunts
Results from recent multicenter randomized clinical trials are providing glaucoma surgeons with valuable information to guide their use of aqueous shunts.
Preliminary results from a retrospective multicenter chart review study provide further insight on the long-term outcomes after keratoprosthesis surgery.
GALILEO: Aflibercept provides marked improvement in visual acuity in results from follow-up to 76 weeks
Intravitreal injection of aflibercept provides marked improvement in visual acuity in treatment-naive eyes with macular edema secondary to central retinal vein occlusion in results from follow-up to 76 weeks in the phase III GALILEO study.